WallStreetZenWallStreetZen

NASDAQ: TELO
Telomir Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Telomir Pharmaceuticals revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TELO annual revenue was $0.0, with N/A growth year-over-year.

TELO revenue history

Current Revenue
$0.0
Current Earnings
-$16.5M
Current Profit Margin
0%

Be the first to know when TELO announces revenue.

TELO Revenue History By Year

TELO Yearly RevenueTELO RevenueTELO ChangeTELO Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A

1 of 1

Telomir Pharmaceuticals Revenue FAQ

What was TELO's revenue last quarter?

Telomir Pharmaceuticals (NASDAQ: TELO) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Telomir Pharmaceuticals's revenue was $0.00.

What was Telomir Pharmaceuticals's revenue in 2024?

Telomir Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Telomir Pharmaceuticals make in a day?

Based on Telomir Pharmaceuticals annual revenue for the past three years, TELO makes an average of $0.00 per day.

What was Telomir Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Telomir Pharmaceuticals's revenue has grown null year over year. Telomir Pharmaceuticals's revenue in the past year totaled $0.00.

How much does Telomir Pharmaceuticals make in a year?

Telomir Pharmaceuticals's revenue by year for the past three years is:
  • Telomir Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Telomir Pharmaceuticals's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Telomir Pharmaceuticals's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.